Senior Vice President, Head of Regulatory, Quality and Portfolio Management
Alyssa Wyant has served as our Senior Vice President of Regulatory and Quality since September 2020. Prior to joining us, Ms. Wyant was at EryDel S.p.A, where she served as Senior Vice President, Regulatory Affairs from January 2019 to August 2020. Prior to joining EryDel S.p.A, Ms. Wyant held senior leadership roles at Edge Therapeutics, Inc. and PTC Therapeutics, Inc. Ms. Wyant brings more than 20 years of regulatory affairs experience to Praxis, including having led the creation and implementation of global strategies for the development, registration and post-approval activities for numerous approved products across both CNS and rare diseases. Ms. Wyant received a B.S. in cell and molecular biology from the University of Washington.